Figure 1

Flow diagram of the study population. *Prospective phase II clinical trial (NCT01401192); PET/CT, positron emission tomography/computed tomography; **, ≥60 days; TS, thymidylate synthase; other causes including death due to adverse event, disease progression, or unknown cause.